Philips, a global leader in health technology, has partnered with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of the Tata Memorial Centre, to introduce next-generation Spectral CT imaging in India. This collaboration aims to enhance diagnostic precision, enable earlier disease detection, and support better clinical decision-making for patients with complex cancers.
By integrating advanced imaging technology into routine clinical practice, the partnership reflects a shared commitment to improving cancer diagnosis and treatment outcomes.
Addressing the Growing Need for Accurate Diagnosis
India continues to face a rising burden of cancer and other complex multi-system diseases. Consequently, timely and accurate diagnosis has become increasingly critical.
Diagnostic delays can lead to avoidable patient harm. Moreover, repeated imaging procedures may expose patients to additional radiation, increase anxiety, and prolong treatment timelines—especially in high-volume tertiary care centres. Therefore, adopting advanced diagnostic technologies can play a vital role in improving both patient safety and clinical efficiency.
Spectral CT Enhances Diagnostic Precision
The Philips Spectral CT 7500 enables clinicians to capture detailed spectral information during routine CT scans. As a result, physicians can obtain deeper insights into disease characteristics from a single scan.
Importantly, this technology allows clinicians to make earlier and more confident diagnostic decisions without increasing radiation exposure. In addition, the system can deliver full-body imaging in approximately two seconds, offering richer diagnostic information while significantly reducing the need for repeat scans.
Studies also indicate that the use of spectral CT imaging leads to 36 percent fewer additional diagnostic procedures in complex cancer evaluations. Consequently, patients experience lower radiation exposure, reduced anxiety, and shorter treatment delays.
Industry Perspective on Advancing Diagnostic Care
Bharath Sesha, Managing Director of Philips Indian Subcontinent, emphasised the company’s commitment to enabling precision diagnosis through advanced imaging technologies.
He noted that the collaboration with the Tata Memorial Cancer Centre demonstrates how innovative technology can help clinicians make faster and more accurate decisions. Furthermore, integrating Spectral CT into routine clinical workflows can reduce delays, minimise unnecessary scans, and improve access to timely diagnosis.
According to him, these efforts also support India’s broader goal of strengthening diagnostic infrastructure and improving patient outcomes.
ACTREC Reinforces Commitment to Advanced Cancer Care
Pankaj Chaturvedi, Director of ACTREC at the Tata Memorial Centre, highlighted the importance of accurate and timely diagnosis in cancer treatment.
He stated that the commissioning of Spectral CT at ACTREC reflects the institution’s ongoing commitment to incorporating cutting-edge technology into clinical practice. By providing deeper diagnostic insights from a single scan and improving workflow efficiency, the platform will help clinicians make faster and better-informed treatment decisions.
He also emphasised that the technology has been introduced with the goal of delivering more precise, compassionate, and future-ready cancer care.
Supporting Multiple Clinical Specialties
Beyond oncology, Spectral CT technology will also benefit several other clinical specialties. These include cardiology, neurology, and emergency medicine, where rapid and accurate assessment is crucial for improving patient outcomes.
Earlier this year, on February 7, 2026, ACTREC hosted a joint clinical program titled “Spectral CT: Clinical Publication Compendium.” During the event, leading radiologists unveiled a compendium featuring more than 770 peer-reviewed publications and white papers from across the world.
As per the Philips Press release, the collection highlights how detector-based spectral CT technology enhances diagnostic certainty, optimises radiation dose and contrast use, reduces follow-up examinations, and improves workflow efficiency across diverse clinical applications.
Strengthening India’s Diagnostic Ecosystem
Through this collaboration, Philips aims to further strengthen India’s diagnostic ecosystem by providing healthcare institutions with advanced imaging solutions.
At the same time, ACTREC continues to adopt innovative technologies that significantly enhance patient care. As one of India’s leading comprehensive cancer centres, the institution remains committed to advancing oncology practice nationwide while ensuring that patients receive faster, more accurate diagnoses and a more streamlined treatment journey.